Literature DB >> 27733675

Stroke-induced immunodepression and dysphagia independently predict stroke-associated pneumonia - The PREDICT study.

Sarah Hoffmann1,2, Hendrik Harms3, Lena Ulm1, Darius G Nabavi4, Bruno-Marcel Mackert5, Ingo Schmehl6, Gerhard J Jungehulsing7,8, Joan Montaner9, Alejandro Bustamante9, Marcella Hermans4, Frank Hamilton5, Jos Göhler2, Uwe Malzahn10,11, Carolin Malsch10,12, Peter U Heuschmann10,11,12, Christian Meisel13,14, Andreas Meisel1,2,8.   

Abstract

Stroke-associated pneumonia is a frequent complication after stroke associated with poor outcome. Dysphagia is a known risk factor for stroke-associated pneumonia but accumulating evidence suggests that stroke induces an immunodepressive state increasing susceptibility for stroke-associated pneumonia. We aimed to confirm that stroke-induced immunodepression syndrome is associated with stroke-associated pneumonia independently from dysphagia by investigating the predictive properties of monocytic HLA-DR expression as a marker of immunodepression as well as biomarkers for inflammation (interleukin-6) and infection (lipopolysaccharide-binding protein). This was a prospective, multicenter study with 11 study sites in Germany and Spain, including 486 patients with acute ischemic stroke. Daily screening for stroke-associated pneumonia, dysphagia and biomarkers was performed. Frequency of stroke-associated pneumonia was 5.2%. Dysphagia and decreased monocytic HLA-DR were independent predictors for stroke-associated pneumonia in multivariable regression analysis. Proportion of pneumonia ranged between 0.9% in the higher monocytic HLA-DR quartile (≥21,876 mAb/cell) and 8.5% in the lower quartile (≤12,369 mAb/cell). In the presence of dysphagia, proportion of pneumonia increased to 5.9% and 18.8%, respectively. Patients without dysphagia and normal monocytic HLA-DR expression had no stroke-associated pneumonia risk. We demonstrate that dysphagia and stroke-induced immunodepression syndrome are independent risk factors for stroke-associated pneumonia. Screening for immunodepression and dysphagia might be useful for identifying patients at high risk for stroke-associated pneumonia.

Entities:  

Keywords:  Acute stroke; immunology; infection; inflammation; macrophages

Mesh:

Substances:

Year:  2016        PMID: 27733675      PMCID: PMC5718319          DOI: 10.1177/0271678X16671964

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  40 in total

Review 1.  The immunology of acute stroke.

Authors:  Ángel Chamorro; Andreas Meisel; Anna M Planas; Xabier Urra; Diederik van de Beek; Roland Veltkamp
Journal:  Nat Rev Neurol       Date:  2012-06-05       Impact factor: 42.937

2.  Prevention of stroke-associated pneumonia: where next?

Authors:  Andreas Meisel; Craig J Smith
Journal:  Lancet       Date:  2015-09-03       Impact factor: 79.321

Review 3.  Central nervous system injury-induced immune deficiency syndrome.

Authors:  Christian Meisel; Jan M Schwab; Konstantin Prass; Andreas Meisel; Ulrich Dirnagl
Journal:  Nat Rev Neurosci       Date:  2005-10       Impact factor: 34.870

4.  Factors influencing in-hospital mortality and morbidity in patients treated on a stroke unit.

Authors:  Hans-Christian Koennecke; W Belz; D Berfelde; M Endres; S Fitzek; F Hamilton; P Kreitsch; B-M Mackert; D G Nabavi; C H Nolte; W Pöhls; I Schmehl; B Schmitz; M von Brevern; G Walter; P U Heuschmann
Journal:  Neurology       Date:  2011-08-24       Impact factor: 9.910

5.  Use and misuse of the receiver operating characteristic curve in risk prediction.

Authors:  Nancy R Cook
Journal:  Circulation       Date:  2007-02-20       Impact factor: 29.690

Review 6.  Dysphagia after stroke: incidence, diagnosis, and pulmonary complications.

Authors:  Rosemary Martino; Norine Foley; Sanjit Bhogal; Nicholas Diamant; Mark Speechley; Robert Teasell
Journal:  Stroke       Date:  2005-11-03       Impact factor: 7.914

7.  The Preventive Antibiotics in Stroke Study (PASS): a pragmatic randomised open-label masked endpoint clinical trial.

Authors:  Willeke F Westendorp; Jan-Dirk Vermeij; Elles Zock; Imke J Hooijenga; Nyika D Kruyt; Hans J L W Bosboom; Vincent I H Kwa; Martijn Weisfelt; Michel J M Remmers; Robert ten Houten; A H C M Tobien Schreuder; Sarah E Vermeer; Ewout J van Dijk; Diederik W J Dippel; Marcel G W Dijkgraaf; Lodewijk Spanjaard; Marinus Vermeulen; Tom van der Poll; Jan M Prins; Frederique H Vermeij; Yvo B W E M Roos; Ruud P Kleyweg; Henk Kerkhoff; Matthijs C Brouwer; Aeilko H Zwinderman; Diederik van de Beek; Paul J Nederkoorn
Journal:  Lancet       Date:  2015-01-20       Impact factor: 79.321

8.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

9.  Lipopolysaccharide binding protein, interleukin-10, interleukin-6 and C-reactive protein blood levels in acute ischemic stroke patients with post-stroke infection.

Authors:  Hans Worthmann; Anita B Tryc; Meike Dirks; Ramona Schuppner; Korbinian Brand; Frank Klawonn; Ralf Lichtinghagen; Karin Weissenborn
Journal:  J Neuroinflammation       Date:  2015-01-23       Impact factor: 8.322

10.  Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation.

Authors:  Konstantin Prass; Christian Meisel; Conny Höflich; Johann Braun; Elke Halle; Tilo Wolf; Karsten Ruscher; Ilya V Victorov; Josef Priller; Ulrich Dirnagl; Hans-Dieter Volk; Andreas Meisel
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

View more
  55 in total

Review 1.  Systemic inflammation in hemorrhagic strokes - A novel neurological sign and therapeutic target?

Authors:  Aisha R Saand; Fang Yu; Jun Chen; Sherry H-Y Chou
Journal:  J Cereb Blood Flow Metab       Date:  2019-04-08       Impact factor: 6.200

2.  Lymphocyte-to-monocyte ratio on day 7 is associated with outcomes in acute ischemic stroke.

Authors:  Min-Gyu Park; Min-Kyeung Kim; Song-Hwa Chae; Hyung-Keun Kim; Junhee Han; Kyung-Pil Park
Journal:  Neurol Sci       Date:  2017-10-30       Impact factor: 3.307

3.  Very Low Frequency Heart Rate Variability Predicts the Development of Post-Stroke Infections.

Authors:  Dirk Brämer; Albrecht Günther; Sven Rupprecht; Samuel Nowack; Josephine Adam; Fenja Meyer; Matthias Schwab; Ralf Surber; Otto W Witte; Heike Hoyer; Dirk Hoyer
Journal:  Transl Stroke Res       Date:  2019-01-07       Impact factor: 6.829

Review 4.  Infection as a Stroke Risk Factor and Determinant of Outcome After Stroke.

Authors:  Mitchell S V Elkind; Amelia K Boehme; Craig J Smith; Andreas Meisel; Marion S Buckwalter
Journal:  Stroke       Date:  2020-09-08       Impact factor: 7.914

5.  Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist - The Managing Aftercare for Stroke (MAS-I) study.

Authors:  Benjamin Hotter; Inken Padberg; Andrea Liebenau; Petra Knispel; Sabine Heel; Diethard Steube; Jörg Wissel; Ian Wellwood; Andreas Meisel
Journal:  Eur Stroke J       Date:  2018-04-19

6.  The 100 most-cited articles about the role of neurovascular unit in stroke 2001-2020: A bibliometric analysis.

Authors:  Lv Xie; Bingwei Lu; Yezhi Ma; Jiemin Yin; Xiaozhu Zhai; Chen Chen; Wanqing Xie; Yueman Zhang; Li Zheng; Peiying Li
Journal:  CNS Neurosci Ther       Date:  2021-03-25       Impact factor: 5.243

7.  Association Between Chronic Inflammatory Diseases and Stroke-Associated Pneumonia - An Epidemiological Study.

Authors:  Layne Dylla; Paco S Herson; Sharon N Poisson; John D Rice; Adit A Ginde
Journal:  J Stroke Cerebrovasc Dis       Date:  2021-01-19       Impact factor: 2.136

Review 8.  Best Practice Recommendations for Stroke Patients with Dysphagia: A Delphi-Based Consensus Study of Experts in Turkey-Part I: Management, Diagnosis, and Follow-up.

Authors:  Ebru Umay; Sibel Eyigor; Cumhur Ertekin; Zeliha Unlu; Barin Selcuk; Gulistan Bahat; Ali Yavuz Karahan; Yaprak Secil; Eda Gurcay; Nefati Kıylioglu; Betul Yavuz Keles; Esra Giray; Canan Tikiz; Ilknur Albayrak Gezer; Ayse Yalıman; Ekin Ilke Sen; Meltem Vural; Guleser Saylam; Mazlum Serdar Akaltun; Aylin Sari; Sibel Alicura; Fatih Karaahmet; Murat Inanir; Aylin Demirhan; Banu Aydeniz; Meral Bilgilisoy; Arif Yuksel; Zeynep Alev Ozcete; Yalkın Calik; Ebru Alemdaroglu; Dilek Keskin; Sevnaz Sahin; Mehmet Fevzi Oztekin; Baha Sezgin; Ozgur Karaahmet; Serkan Bengisu; Tanu Yalcin Gokler; Serdar Mercimekci
Journal:  Dysphagia       Date:  2021-03-09       Impact factor: 3.438

9.  Value of Combining of the NLR and the Fibrinogen Level for Predicting Stroke-Associated Pneumonia.

Authors:  Wei Cheng; Lichang Chen; Huapeng Yu; Dongzhu Lu; Rong Yu; Jian Chen
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-28       Impact factor: 2.570

Review 10.  Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections.

Authors:  Júlia Faura; Alejandro Bustamante; Francesc Miró-Mur; Joan Montaner
Journal:  J Neuroinflammation       Date:  2021-06-06       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.